18 results
management differential lupus algorithm erythematosus sle systemic antinuclear druginduced summary table treatment vasculitis antibodies arterial arteritis autoantibodies autoimmune bleeding cancer
Algorithm for the Evaluation and Management of Sickle Cell Crises Clinical Manifestations and Management #Diagnosis #Management #Hematology #SickleCell
Algorithm for the Evaluation ... Sickle Cell Crises Clinical ... Management #Diagnosis ... #Management #Hematology ... Workup #Algorithm #Ddxof
Differential Diagnosis of Hypoglycemia Evaluation of Hypoglycemia Patients with known diabetes who are not systemically ill and can
of Hypoglycemia Evaluation ... #EM #IM #Hypoglycemia ... Differential #Algorithm #Drugs ... #Malignancy #Exogenous ... #Hypoglycemic #Ddxof
Antinuclear Antibodies (ANA) ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
likely it will be clinically ... associated with a +ANA ... Non-Rheumatic Diseases: Malignancy ... #patterns #rheumatology ... #diagnosis #differential
Venous Thrombosis vs Arterial Thrombosis - Differential Diagnosis Framework VENOUS THROMBOSIS • Acquired Risk Factors: - >48 hours
- Differential Diagnosis ... • Intravenous Drug ... Pregnancy • Drugs ... atheroemboli) • Aorta ... pathophysiology #hematology
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Workup: - ANA ... Workup: - ANA ... comparison #table #rheumatology ... #diagnosis #management
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Erythematosus (SLE) - Diagnosis ... 40, F:M 9:1 • Clinical ... Workup: - ANA ... Erythematosus #Diagnosis ... Management #Summary #rheumatology
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... findings (ANA, ... Serositis Labs: • ANA ... antibodies • (-) ANA ... #Rheumatology
Antinuclear antibodies and Systemic lupus Anti-dsDNA 60-80% Association with disease activity (when with Farr assay) and lupus nephritis. Can
searched for when ANA ... SLE (60-70%) & drug-induced ... -15% If SLE is clinically ... #rheumatology # ... table #ANA
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
accumulation of clinical ... Assessment • Clinical ... immune deficiency, Drugs ... inhibitors under evaluation ... treatment #summary #rheumatology
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
- Differential Diagnosis ... < 30 years - Aorta ... • GCA: - Aorta ... LFT • ESR • ANA ... #rheumatology #
No results found for "ddxof evaluation aorta aaa em malignancy clinical drugs diagnosis rheumatology ana hematology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ddxof #evaluation #aorta #aaa #em #malignancy #clinical #drugs #diagnosis #rheumatology #ana #hematology